Pasta maker Barilla funds cell therapy research for coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association “The Cure Alliance” to fund research on a COVID-19 therapy based on stem cells, the group said on Monday.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the U.S. Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous 2 million euro ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company’s home country.
Reuters
Related news
Omnichannel Scale 2024: How can Hungarian retailers remain competitive?
The Omnichannel Scale 2024 study gives a comprehensive overview of…
Read more >According to a study, e-mobility is also expanding in domestic transport
The greening of freight transport is inevitable, and the proportion…
Read more >This is why many people still choose shops instead of buying online
According to a recent EY international survey of more than…
Read more >Related news
The Night of Modern Factories event series is becoming more and more successful
The national online and live event series The Night of…
Read more >The new competitiveness-enhancing EU tenders were presented at the information forum of the Budapest Chamber amid huge entrepreneurial interest.
After a gap of more than a decade, EU tenders…
Read more >The most exciting agricultural technology event is coming
The rebirth of agriculture in the struggles of the generations,…
Read more >